| Literature DB >> 26939069 |
Valérie Pittet1, Carla Vaucher1, Michel H Maillard2, Marc Girardin3, Philippe de Saussure3, Bernard Burnand1, Gerhard Rogler4, Pierre Michetti5.
Abstract
BACKGROUND: Inflammatory Bowel Disease (IBD) patients are confronted with needs and concerns related to their disease. AIM: To explore information expectations of patients included in a national bilingual IBD cohort in Switzerland (SIBDC).Entities:
Mesh:
Year: 2016 PMID: 26939069 PMCID: PMC4777374 DOI: 10.1371/journal.pone.0150620
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Comparison of patients’ characteristics between responders and non-responders to the questionnaire on information needs.
Values are number and percentages unless specified.
| Variables | All | Responders | Non-responders | p-value |
|---|---|---|---|---|
| 1506 | 728 (48.3) | 778 (51.7) | ||
| 954 (63.3) | 460 (63.2) | 494 (63.5) | 0.618 | |
| 763 (50.7) | 382 (52.5) | 381 (49.0) | 0.174 | |
| <0.001 | ||||
| 532 (35.3) | 217 (29.8) | 315 (40.5) | ||
| 559 (37.1) | 292 (40.1) | 267 (34.3) | ||
| 415 (27.6) | 219 (30.1) | 196 (25.2) | ||
| 0.029 | ||||
| 1198 (79.6) | 562 (77.2) | 636 (81.8) | ||
| 308 (20.4) | 166 (22.8) | 142 (18.2) | ||
| 0.231 | ||||
| 511 (33.9) | 234 (32.1) | 277 (35.6) | ||
| 581 (38.6) | 281 (38.6) | 300 (38.6) | ||
| 414 (27.5) | 201 (25.8) | 201 (25.8) | ||
| 0.076 | ||||
| 877 (58.2) | 407 (55.9) | 470 (60.4) | ||
| 629 (41.8) | 321 (44.1) | 308 (39.6) | ||
| 698 (46.4) | 335 (46.0) | 363 (46.7) | 0.803 | |
| 190 (13.7) | 85 (12.7) | 105 (14.6) | 0.309 | |
| 600 (50.4) | 366 (53.2) | 234 (46.6) | 0.025 | |
| 0.005 | ||||
| 181 (14.8) | 85 (12.0) | 96 (18.6) | ||
| 674 (55.2) | 399 (56.5) | 275 (53.4) | ||
| 366 (30.0) | 222 (31.4) | 144 (28.0) | ||
| 0.914 | ||||
| 840 (69.8) | 485 (70.0) | 355 (69.5) | ||
| 62 (5.2) | 35 (5.0) | 27 (5.3) | ||
| 157 (13.0) | 87 (12.6) | 70 (13.7) | ||
| 145 (12.0) | 86 (12.4) | 59 (11.5) |
Comparison of sources of information consulted by the 346 patients who searched for information at the time of 1st symptoms, and the 385 patients who searched for information at the time of diagnostic.
| All | Gender | Diagnosis | |||||
|---|---|---|---|---|---|---|---|
| Sources of information | N (%) | Female N (%) | Male N (%) | p-value | CD N (%) | UC N (%) | p-value |
| 228 (65.9) | 125 (65.4) | 103 (66.4) | 0.844 | 125 (67.6) | 103 (64.0) | 0.482 | |
| 18 (5.2) | 13 (6.8) | 5 (3.2) | 0.152 | 7 (3.8) | 11 (6.8) | 0.231 | |
| 26 (7.5) | 15 (7.8) | 11 (7.1) | 0.840 | 16 (8.6) | 10 (6.2) | 0.421 | |
| 127 (36.7) | 54 (28.3) | 73 (47.1) | 57 (30.8) | 70 (43.5) | |||
| 103 (29.8) | 62 (32.5) | 41 (26.4) | 0.224 | 59 (31.9) | 44 (27.3) | 0.355 | |
| 52 (45.2) | 58 (60.4) | 53 (46.4) | 57 (58.7) | 0.075 | |||
| 1 (41.7) | 5 (20.0) | 0.394 | 3 (42.8) | 3 (30.0) | 0.585 | ||
| 6 (46.1) | 4 (50.0) | 0.864 | 5 (45.4) | 5 (50.0) | 0.835 | ||
| 19 (39.6) | 43 (62.3) | 27 (50.0) | 35 (55.6) | 0.548 | |||
| 22 (38.6) | 22 (61.1) | 22 (40.7) | 22 (56.4) | 0.135 | |||
| 123 (31.9) | 71 (31.3) | 52 (32.9) | 0.735 | 80 (37.2) | 43 (25.3) | ||
| 29 (7.5) | 17 (7.5) | 12 (7.6) | 0.969 | 12 (5.6) | 17 (10.0) | 0.103 | |
| 57 (14.8) | 36 (15.9) | 21 (13.3) | 0.485 | 33 (15.4) | 24 (14.1) | 0.736 | |
| 175 (45.4) | 93 (41.0) | 82 (51.9) | 90 (41.9) | 85 (50.0) | 0.111 | ||
| 92 (23.9) | 58 (21.5) | 34 (25.6) | 0.362 | 51 (23.7) | 41 (24.1) | 0.928 | |
Fig 1Topics of information searched according to disease phases.
Topics of information consulted by the patients who searched for information, according to phase of the disease.
| At the time of diagnosis | When disease is active | When disease is quiet | |
|---|---|---|---|
| 385 | 382 | 284 | |
| 126 (32.7) | 93 (24.3) | 161 (56.7) | |
| Long term disease progression | 85 | 41 | 57 |
| Origins of the disease | 35 | 17 | 12 |
| Epidemiological/statistical results | 14 | 4 | 2 |
| Can we cure the disease? | 11 | 12 | 15 |
| Trends in mortality | 10 | 4 | 0 |
| Recent advances in research | 6 | 11 | 71 |
| Hereditary | 6 | 4 | 5 |
| Clinical trials / research on new drugs | 5 | 23 | 74 |
| 105 (27.3) | 164 (42.9) | 86 (30.3) | |
| Adverse events of drugs | 15 | 39 | 15 |
| Information on drugs or other therapies | 87 | 104 | 53 |
| Information on surgery | 12 | 40 | 9 |
| Alternative or complementary medicines | 15 | 48 | 24 |
| Information on change / stop of treatment | 0 | 4 | 14 |
| 95 (24.9) | 111 (29.1) | 80 (28.2) | |
| Nutrition | 45 | 37 | 30 |
| Risk factors and prevention of flares | 20 | 52 | 40 |
| Daily management | 19 | 25 | 19 |
| Quality of life and consequences on life habits | 18 | 20 | 18 |
| Gynaecology / Pregnancy | 12 | 10 | 5 |
| Psychological factors / psychological help | 11 | 21 | 24 |
| Communication aspects (in the family, at work) | 1 | 0 | 1 |
| Legal aspects (absence at work, disability) | 1 | 5 | 5 |
| 200 (52.0) | 78 (20.4) | 37 (13.0) | |
| Generalities about the disease | 193 | 64 | 29 |
| Extra-intestinal manifestations | 10 | 10 | 3 |
| Cancer | 4 | 7 | 3 |
| Vaccination | 1 | 0 | 3 |
| 44 (11.4) | 31 (8.1) | 8 (2.8) | |
| Testimonies | 26 | 13 | 1 |
| Exchanges | 17 | 16 | 7 |
| Support groups | 5 | 5 | 1 |
| 7 (1.8) | 7 (1.8) | 9 (3.2) |
Fig 2Topics of information searched at diagnosis, according to gender (A) and type of disease (B).
Fig 4Topics of information searched when in remission by gender (A), type of disease (B) and age (C).
Fig 3Topics of information searched during active disease phases by gender (A), type of disease (B) and age (C).
Adjusted* odds ratios (95% confidence intervals) for searching information when disease is active or quiescent, stratified by diagnostic.
| Active CD | CD in remission | Active UC | UC in remission | |||||
|---|---|---|---|---|---|---|---|---|
| N (%) | OR (95%CI) | N (%) | OR (95%CI) | N (%) | OR (95%CI) | N (%) | OR (95%CI) | |
| 116 (51.8) | 1.12 (0.76–1.67) | 88 (39.3) | 1.04 (0.69–1.57) | 93 (58.9) | 1.39 (0.88–2.18) | 54 (34.2) | 0.70 (0.44–1.11) | |
| 44.8 (13.6) | 1.00 (0.98–1.01) | 46.0 (15.1) | 42.0 (12.5) | 45.7 (13.0) | 1.01 (0.99–1.02) | |||
| 75 (48.4) | 0.88 (0.59–1.32) | 67 (43.2) | 1.35 (0.89–2.05) | 59 (52.2) | 0.85 (0.52–1.38) | 51 (45.1) | ||
| 13.8 (9.7) | 1.01 (0.99–1.04) | 13.2 (9.8) | 0.99 (0.97–1.01) | 10.8 (9.3) | 1.02 (0.99–1.05) | 11.4 (9.9) | 1.01 (0.98–1.03) | |
| 93 (50.0) | 0.78 (0.50–1.22) | 77 (41.4) | 0.90 (0.57–1.42) | 97 (54.2) | 1.01 (0.61–1.65) | 74 (41.1) | 1.20 (0.73–1.98) | |
| 26 (56.5) | 1.30 (0.69–2.44) | 20 (43.4) | 1.22 (0.65–2.30) | 20 (52.6) | 0.82 (0.41–1.65) | 15 (38.4) | 1.03 (0.51–2.08) | |
| 27 (56.3) | 1.00 | 19 (39.6) | 1.00 | 17 (46.0) | 1.00 | 11 (29.7) | 1.00 | |
| 108 (46.0) | 0.68 (0.36–1.28) | 88 (37.5) | 0.96 (0.50–1.84) | 85 (52.2) | 1.22 (0.58–2.57) | 61 (37.2) | 1.40 (0.63–3.08) | |
| 64 (58.2) | 1.14 (0.56–2.29) | 47 (42.7) | 1.21 (0.59–2.47) | 69 (61.6) | 1.83 (0.82–4.05) | 50 (44.6) | 1.89 (0.81–4.35) | |
| 135 (52.9) | 1.00 | 93 (36.5) | 1.00 | 123 (53.7) | 1.00 | 88 (38.3) | 1.00 | |
| 7 (31.8) | 0.54 (0.20–1.47) | 12 (54.6) | 12 (92.3) | 2 (15.4) | 0.29 (0.06–1.45) | |||
| 28 (51.9) | 0.86 (0.46–1.60) | 25 (46.3) | 1.29 (0.68–2.42) | 20 (60.6) | 1.23 (0.56–2.70) | 14 (42.4) | 1.33 (0.61–2.87) | |
| 26 (47.3) | 0.65 (0.33–1.28) | 23 (41.8) | 0.72 (0.36–1.44) | 14 (45.2) | 1.10 (0.43–2.81) | 15 (48.4) | 1.25 (0.49–3.13) | |
| 79 (53.0) | 1.14 (0.75–1.73) | 55 (36.9) | 0.89 (0.58–1.36) | 22 (48.9) | 0.69 (0.36–1.32) | 21 (46.7) | 1.50 (0.78–2.86) | |
$mean (SD)
*adjusted for age, gender, disease duration
Adjusted* odds ratios (95% confidence intervals) for searching information when disease is active or quiescent, stratified by diagnostic.
| Active CD | CD in remission | Active UC | UC in remission | |||||
|---|---|---|---|---|---|---|---|---|
| N (%) | OR (95%CI) | N (%) | OR (95%CI) | N (%) | OR (95%CI) | N (%) | OR (95%CI) | |
| 154 (48.7) | 1.00 | 117 (37.0) | 1.00 | 146 (54.1) | 1.00 | 102 (37.8) | 1.00 | |
| 28 (60.9) | 1.47 (0.77–2.80) | 26 (56.5) | 19 (63.3) | 1.48 (0.66–3.29) | 16 (53.3) | 1.80 (0.83–3.89) | ||
| 17 (56.7) | 1.40 (0.65–3.01) | 11 (36.7) | 0.92 (0.42–2.04) | 7 (53.9) | 0.92 (0.29–2.93) | 4 (28.6) | 0.65 (0.19–2.17) | |
| 118 (46.3) | 1.00 | 95 (37.2) | 1.00 | 120 (53.6) | 1.00 | 86 (38.4) | 1.00 | |
| 40 (52.0) | 1.26 (0.75–2.12) | 37 (48.0) | 1.55 (0.92–2.61) | 32 (58.2) | 1.22 (0.66–2.24) | 23 (41.8) | 1.17 (0.63–2.14) | |
| 41 (68.3) | 22 (36.7) | 1.04 (0.57–1.90) | 20 (58.8) | 1.08 (0.51–2.30) | 13 (37.1) | 0.98 (0.46–2.08) | ||
| 82 (45.1) | 1.00 | 65 (35.7) | 1.00 | 69 (47.6) | 1.00 | 51 (35.2) | 1.00 | |
| 42 (53.9) | 1.50 (0.87–2.58) | 36 (46.1) | 1.67 (0.96–2.89) | 40 (58.0) | 1.47 (0.81–2.66) | 30 (43.5) | 1.48 (0.81–2.68) | |
| 32 (49.2) | 1.23 (0.69–2.19) | 27 (41.5) | 1.33 (0.74–2.39) | 32 (62.8) | 1.86 (0.96–3.63) | 17 (33.3) | 0.93 (0.47–1.84) | |
| 45 (65.2) | 28 (40.6) | 1.40 (0.77–2.52) | 31 (64.6) | 1.82 (0.91–3.64) | 24 (49.0) | |||
| 24.0 (5.1) | 0.98 (0.94–1.02) | 24.1 (4.8) | 0.99 (0.95–1.04) | 24.6 (5.0) | 0.98 (0.94–1.02) | 25.7 (5.1) | 1.00 (0.95–1.04) | |
| 2.1 (2.8) | 2.1 (2.7) | 2.0 (2.2) | 1.9 (2.1) | |||||
| 3.7 (4.1) | 3.3 (3.9) | 1.03 (0.98–1.09) | 3.1 (3.3) | 3.1 (3.3) | ||||
| 3.8 (3.3) | 3.7 (3.4) | 3.0 (2.5) | 2.9 (2.7) | 1.05 (0.96–1.14) | ||||
| 47.2 (43.3) | 0.98 (0.96–1.00) | 46.8 (10.3) | 0.98 (0.96–1.00) | 48.6 (9.3) | 48.9 (9.1) | 0.99 (0.96–1.01) | ||
| 43.3 (11.9) | 44.4 (11.1) | 0.98 (0.97–1.00) | 45.0 (10.6) | 0.97 (0.95–1.00) | 44.7 (11.3) | |||
| 54.4 (10.2) | 55.6 (10.1) | 0.98 (0.96–1.00) | 56.3 (10.0) | 57.7 (10.7) | 0.99 (0.97–1.02) | |||
| 23.7 (6.2) | 24.2 (6.2) | 0.98 (0.95–1.02) | 24.4 (5.7) | 25.1 (6.1) | 0.98 (0.95–1.02) | |||
| 63.1 (12.8) | 64.0 (12.4) | 0.98 (0.97–1.00) | 64.5 (11.5) | 65.3 (11.7) | 0.98 (0.96–1.00) | |||
| 29.2 (6.8) | 29.5 (6.5) | 0.98 (0.94–1.01) | 30.2 (6.4) | 30.0 (6.8) | 0.96 (0.92–1.00) | |||
PTSDS = posttraumatic stress disorder symptoms
$mean (SD)
*adjusted for age, gender, disease duration